Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients

International Journal of COPD

Volumn 2, Issue 1, 2007, Pages 71-76

  Borrill, Zoë L ^a   Starkey, R Cerys ^a   Singh, S Dave ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

8 isoprostane; Chronic obstructive pulmonary disease; Exhaled breath condensate; Leukotriene B4; Reproducibility

Indexed keywords

8 ISOPROSTANE; LEUKOTRIENE B4;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXPIRED AIR; FEMALE; HUMAN; MALE; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE;

BIOLOGICAL MARKERS; BREATH TESTS; DATA INTERPRETATION, STATISTICAL; DINOPROST; FEMALE; HUMANS; LEUKOTRIENE B4; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS;

EID: 34250309247     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: 10.2147/copd.2007.2.1.71     Document Type: Article

References (14)

1. 4 and 8-isoprostane in exhaled breath condensate of patients with exacerbation of COPD. Thorax, 58:294-8.
2. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between 2 methods of clinical measurement. Lancet, 1: 307-10.
3. Borrill Z, Starkey C, Vestbo J, et al. 2005. Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J, 25:269-74.
4. Cap P, Chladek J, Pehal F, et al. 2004. Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients. Thorax, 59:465-70.
5. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, et al. 2003. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J, 21:589-93.
6. Csoma ZS, Kharitonov XA, Balint B, et al. 2002. Increased leukotrienes in exhaled breath condensate in childhood asthma, Am J Respir Crit Care Med, 166:1345-9.
7. Effros RM, Biller J, Foss B, et al. 2003. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med, 168:1500-15.
8. Horvath I, Hunt J, Barnes PJ, et al; ATS/ERS Task Force on Exhaled Breath Condensate. 2005. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J, 26:523-48.
9. Kostikas K, Papatheodorou G, Psathakis K, et al. 2003. Oxidative stress in expired breath condensate in patients with COPD. Chest, 124:1373-80.
10. Montuschi P, Collins JV, Ciabattoni G, et al. 2000. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med, 162:1175-7.
11. Montuschi P, Kharitonov SA, Ciabattoni G, et al. 2003. Exhaled leukotrienes and prostaglandins in COPD. Thorax, 58:585-8.
12. 4 in exhaled breath condensate. Rapid Commun Mass Spectrom, 18:2723-29.
13. [NCCCC] National Collaborating Centre for Chronic Conditions. 2004. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59(Suppl 1): 1-232.
14. van Hoydonck PGA, Wuyts WA, Vanaudenaerde BM, et al. 2004. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J, 23:189-92.